Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation. 2022;145:e895–1032.
Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure: endorsed by the Canadian heart failure society, heart failure association of India, cardiac society of Australia and new Zealand, and Chinese heart failure association. Eur J Heart Fail. 2021;23:352–80.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol. 2013;62:e147–239.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975.
Tsuji K, Sakata Y, Nochioka K, Miura M, Yamauchi T, Onose T, et al. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 study. Eur J Heart Fail. 2017;19:1258–69.
Savarese G, Vedin O, D’Amario D, Uijl A, Dahlström U, Rosano G, et al. Prevalence and prognostic implications of longitudinal ejection fraction change in heart failure. JACC Heart Fail. 2019;7:306–17.
Rickenbacher P, Kaufmann BA, Maeder MT, Bernheim A, Goetschalckx K, Pfister O, et al. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Eur J Heart Fail. 2017;19:1586–96.
Article CAS PubMed Google Scholar
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for Device-Based therapy of cardiac rhythm abnormalities: a report of the American college of cardiology/american heart association task force on practice guidelines (Writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia Devices) developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons. J Am Coll Cardiol. 2008;51:e1–62.
Baldasseroni S, De Biase L, Fresco C, Marchionni N, Marini M, Masotti G, et al. Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). Eur Heart J. 2002;23:1692–98.
Article CAS PubMed Google Scholar
Henneman MM, van der Wall EE, Ypenburg C, Bleeker GB, van de Veire NR, Marsan NA, et al. Nuclear imaging in cardiac resynchronization therapy. J Nucl Med. 2007;48:2001–10.
Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, GarrigueS, et al. Cardiac resynchronization therapy: part 1–issues before device implantation. J Am Coll Cardiol. 2005;46:2153–67.
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117:2608–16.
Doi T, Nakata T, Noto T, Mita T, Yuda S, Hashimoto A. Improved risk-stratification in heart failure patients with mid-range to severe abnormalities of QRS duration and systolic function using mechanical dyssynchrony assessed by myocardial perfusion-gated SPECT. J Nucl Cardiol. 2022;29:1611–25.
Doi T, Nakata T, Yuda S, Hashimoto A. Synergistic prognostication of left ventricular hypertrophy and three-dimensional mechanical dyssynchrony in heart failure. ESC Heart Fail. 2020;7:361–70.
PubMed PubMed Central Google Scholar
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28:1–e3914.
Daimon M, Iwano H, Onishi T, Ohara T, Tanaka H, Hirano Y, et al. Guideline from the Japanese society of echocardiography: guidance for the management and maintenance of echocardiography equipment: 2022 focused update. J Echocardiogr. 2022;20:195–200.
Article PubMed PubMed Central Google Scholar
Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45:602–11.
Article CAS PubMed Google Scholar
Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart Failure) study. J Am Coll Cardiol. 2010;55:2212–21.
Verschure DO, Poel E, Travin MI, Henzlova MJ, Jain D, Jacobson AF, et al. A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure. Eur Heart J Cardiovasc Imaging. 2022;23:1201–9.
Inaguma D, Morii D, Kabata D, Yoshida H, Tanaka A, Koshi-Ito E, et al. Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients. PLoS ONE. 2019;14:e0221352.
Article CAS PubMed PubMed Central Google Scholar
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427–520.
Shenkman HJ, Pampati V, Khandelwal AK, McKinnon J, Nori D, Kaatz S, et al. Congestive heart failure and QRS duration: Establishing prognosis study. Chest. 2002;122:528–34.
Khan NK, Goode KM, Cleland JG, Rigby AS, Freemantle N, Eastaugh J, et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge. Eur J Heart Fail. 2007;9:491–501.
Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC Jr, et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. JAMA. 2008;299:2656–66.
Article CAS PubMed Google Scholar
Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260–9.
Article CAS PubMed Google Scholar
Carità P, Corrado E, Pontone G, Curnis A, Bontempi L, Novo G, et al. Non-responders to cardiac resynchronization therapy: insights from multimodality imaging and electrocardiography. A brief review. Int J Cardiol. 2016;225:402–07.
Varma N, Sogaard P, Bax JJ, Abraham WT, Borer JS, Dickstein K, et al. Interaction of left ventricular size and sex on outcome of cardiac resynchronization therapy among patients with a narrow QRS duration in the echocrt trial. J Am Heart Assoc. 2018;7:e009592.
Article PubMed PubMed Central Google Scholar
Zhang Q, van Bommel RJ, Fung JW, Chan JY, Bleeker GB, Ypenburg C, et al. Tissue doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapy. Heart. 2009;95:1085–90.
Article CAS PubMed Google Scholar
Bazoukis G, Thomopoulos C, Tse G, Tsioufis K, Nihoyannopoulos P. Global longitudinal strain predicts responders after cardiac resynchronization therapy-a systematic review and meta-analysis. Heart Fail Rev. 2022;27:827–36.
Moulin T, Hamon D, Djouadi K, D’Humières T, Elbaz N, Boukantar M, et al. Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real-world experience. ESC Heart Fail. 2022;9:3101–12.
Article PubMed PubMed Central Google Scholar
Weigand S, Karl M, Brkić A, Lennerz C, Grebmer C, Blažek P, et al. The impact of multipole pacing on left ventricular function in patients with cardiac resynchronization therapy - A real-time three-dimensional echocardiography approach. Int J Cardiol. 2018;272:238–43.
Comments (0)